| scholarly article | Q13442814 |
| P50 | author | Soonchan Park | Q88926287 |
| P2093 | author name string | Yi Wang | |
| Geon-Ho Jahng | |||
| Kyung Mi Lee | |||
| Chang-Woo Ryu | |||
| Sun Jung Rhee | |||
| Soo Yeol Lee | |||
| Hak Young Rhee | |||
| Hyug-Gi Kim | |||
| P2860 | cites work | Susceptibility-Weighted Imaging: Technical Aspects and Clinical Applications, Part 1 | Q22064541 |
| Iron-export ferroxidase activity of β-amyloid precursor protein is inhibited by zinc in Alzheimer's disease | Q24298553 | ||
| Amyloid PET in clinical practice: Its place in the multidimensional space of Alzheimer's disease | Q27009411 | ||
| Memory loss in Alzheimer's disease | Q27687485 | ||
| Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease | Q27860795 | ||
| The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics | Q27860914 | ||
| Mild cognitive impairment: clinical characterization and outcome | Q28140626 | ||
| A fast diffeomorphic image registration algorithm | Q28243996 | ||
| Characterization of a chromosomal toxin-antitoxin, Rv1102c-Rv1103c system in Mycobacterium tuberculosis | Q28487192 | ||
| In vivo quantitative susceptibility mapping (QSM) in Alzheimer's disease | Q30701725 | ||
| Quantitative susceptibility mapping (QSM): Decoding MRI data for a tissue magnetic biomarker | Q30837513 | ||
| Susceptibility-weighted imaging and quantitative susceptibility mapping in the brain | Q30856540 | ||
| Imaging iron stores in the brain using magnetic resonance imaging | Q30983609 | ||
| High-field magnetic resonance imaging of brain iron: birth of a biomarker? | Q33208658 | ||
| Quantitative susceptibility map reconstruction from MR phase data using bayesian regularization: validation and application to brain imaging | Q33517036 | ||
| Increased iron and free radical generation in preclinical Alzheimer disease and mild cognitive impairment | Q33740552 | ||
| Mild cognitive impairment: potential pharmacological treatment options | Q33911331 | ||
| Structural covariance of superficial white matter in mild Alzheimer's disease compared to normal aging. | Q33964442 | ||
| Current concepts in mild cognitive impairment | Q34104314 | ||
| A novel background field removal method for MRI using projection onto dipole fields (PDF) | Q34169416 | ||
| Morphology enabled dipole inversion (MEDI) from a single-angle acquisition: comparison with COSMOS in human brain imaging. | Q34175846 | ||
| MRI estimates of brain iron concentration in normal aging using quantitative susceptibility mapping | Q35663179 | ||
| Ferritin levels in the cerebrospinal fluid predict Alzheimer's disease outcomes and are regulated by APOE | Q35775365 | ||
| The contribution of myelin to magnetic susceptibility-weighted contrasts in high-field MRI of the brain. | Q35784639 | ||
| Patterns of Brain Iron Accumulation in Vascular Dementia and Alzheimer's Dementia Using Quantitative Susceptibility Mapping Imaging | Q35927317 | ||
| Accuracy of the morphology enabled dipole inversion (MEDI) algorithm for quantitative susceptibility mapping in MRI. | Q36732418 | ||
| Ferrous iron formation following the co-aggregation of ferric iron and the Alzheimer's disease peptide β-amyloid (1-42). | Q37735395 | ||
| Morphology enabled dipole inversion for quantitative susceptibility mapping using structural consistency between the magnitude image and the susceptibility map. | Q40281880 | ||
| Evidence that the beta-amyloid plaques of Alzheimer's disease represent the redox-silencing and entombment of abeta by zinc | Q40881389 | ||
| Regional distribution of iron and iron-regulatory proteins in the brain in aging and Alzheimer's disease | Q41117111 | ||
| Reducing the object orientation dependence of susceptibility effects in gradient echo MRI through quantitative susceptibility mapping | Q41341482 | ||
| Increased iron levels and decreased tissue integrity in hippocampus of Alzheimer's disease detected in vivo with magnetic resonance imaging | Q43509556 | ||
| Distinct cerebrospinal fluid amyloid-beta peptide signatures in cognitive decline associated with Alzheimer's disease and schizophrenia. | Q45420612 | ||
| Multiple methods for workshop evaluation, 1994-95. | Q46720720 | ||
| Quantitative susceptibility mapping for investigating subtle susceptibility variations in the human brain. | Q47670330 | ||
| Phases of A beta-deposition in the human brain and its relevance for the development of AD. | Q48567985 | ||
| Microanalysis of Alzheimer disease NFT and plaques. | Q52058619 | ||
| Mild cognitive impairment. When is it a precursor to Alzheimer's disease? | Q74343854 | ||
| P921 | main subject | Alzheimer's disease | Q11081 |
| P304 | page(s) | 429-438 | |
| P577 | publication date | 2017-08-24 | |
| P1433 | published in | NeuroImage: Clinical | Q22907265 |
| P1476 | title | Quantitative susceptibility mapping to evaluate the early stage of Alzheimer's disease | |
| P478 | volume | 16 |
| Q89808090 | Brain iron deposition is linked with cognitive severity in Parkinson's disease |
| Q90639131 | Combined Diffusion Tensor Imaging and Quantitative Susceptibility Mapping Discern Discrete Facets of White Matter Pathology Post-injury in the Rodent Brain |
| Q99623680 | Cortical iron disrupts functional connectivity networks supporting working memory performance in older adults |
| Q58608684 | Quantification of Macrophages in High-Grade Gliomas by Using Ferumoxytol-enhanced MRI: A Pilot Study |
| Q91744562 | Quantitative magnetic susceptibility assessed by 7T magnetic resonance imaging in Alzheimer's disease caused by streptozotocin administration |
| Q51762367 | Simultaneous quantitative susceptibility mapping and Flutemetamol-PET suggests local correlation of iron and β-amyloid as an indicator of cognitive performance at high age. |
Search more.